TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Meteor lights up night sky above eastern U.S.
  2. Serra boys soccer preps for early-season clash
  3. Pitt football coach Chryst refutes analyst Wannstedt’s opinion
  4. Microsoft to pay $2.5B for ‘Minecraft’ maker
  5. Investors play it safe before Federal Reserve meeting
  6. Van Voorhis man charged for Monessen cell incident
  7. Pirates analyst Kent Tekulve recovering after heart transplant
  8. Ringgold senior Umbel introduced to politics as Senate page
  9. Business roundup: Mylan reaches deal on hepatitis C drug; U.S. factory output drops; more
  10. Meyers Player of the Week
  11. Belle Vernon man facing child sex assault charges
Subscribe today! Click here for our subscription offers.